Johnson & Johnson will allocate 86 percent fewer doses across the United States next week than are currently being allocated, according to C.D.C. data, dealing a setback to a national vaccination campaign that has just found its footing. Around 15 million doses at a Baltimore factory had been contaminated, delaying the plant’s authorization.
